Recent Updates
Recently added Catalysts
INSP Positive Sentiment Score: 70/100

Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference

Thursday, August 25, 2022 1 min read
Key Takeaway: Inspire Medical Systems, Inc. will present at the Wells Fargo 2022 Healthcare Conference on September 8, 2022. The presentation will highlight their innovative solutions for obstructive sleep apnea, including their FDA-approved Inspire therapy. Attendees can access the presentation via a live webcast, with a replay available afterward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Inspire Medical Systems is presenting at a notable healthcare conference.
  • The company focuses on innovative solutions for obstructive sleep apnea.
  • Inspire therapy is the first FDA-approved neurostimulation technology for this condition.

Full Press Release Details

MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA.
Inspire is scheduled to present at 3:10 p.m. Eastern Time. The presentation will be accessible via a live webcast at:https://event.webcasts.com/starthere.jsp?ei=1563770&tp_key=f801e95b55&tp_special=8
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website athttps://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visitwww.inspiresleep.com.

Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443

Frequently Asked Questions

When will Inspire Medical Systems present at the conference?

Inspire Medical Systems will present on September 8, 2022, at 3:10 p.m. ET.

How can I access the presentation?

The presentation will be accessible via a live webcast on their website.

What is Inspire's focus in medical technology?

Inspire focuses on innovative, minimally invasive solutions for obstructive sleep apnea.

What is the Inspire therapy?

Inspire therapy is the first FDA-approved neurostimulation technology for sleep apnea.

Tags: INSP Viatris Investor Conferences Healthcare Inspire Medical Systems obstructive sleep apnea Wells Fargo Conference FDA-approved therapy neurostimulation technology
Last updated: Aug 25, 2022